• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Gendex buy adds to Del's sales growth

Article

Del Global Technologies of Valhalla, NY, reported strong growthin both revenues and earnings for fiscal 1996, thanks to a combinationof internal revenue growth and the addition of sales from x-rayvendor Gendex, which Del bought earlier this year (SCAN

Del Global Technologies of Valhalla, NY, reported strong growthin both revenues and earnings for fiscal 1996, thanks to a combinationof internal revenue growth and the addition of sales from x-rayvendor Gendex, which Del bought earlier this year (SCAN 12/27/95).

For the year (end-August), Del reported net sales of $43.7million, a company record and a figure that is 35% higher thanthe $32.6 million in revenues reported in fiscal 1995. Net incomewas $2.9 million, compared with $1.9 million in the prior year.

Del's revenues grew at an even greater rate in the fourth quarter,as the Gendex operations began contributing revenue in the middleof Del's third quarter. Del's revenues jumped 45% to $14.4 million,compared with $9.9 million in the fourth quarter of 1995. Netincome for the period was $970,000, compared with $427,000 inthe fourth quarter of 1995.

Medical imaging sales now contribute 59% of Del's revenues,according to chief executive Leonard Trugman. Del saw growth insales of power conversion subsystems for medical imaging applications,and the company's backlog stood at $23 million at year end, Trugmansaid. The company is planning to display a new neonatal imagingsystem at next month's Radiological Society of North America meeting.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.